The Continuous Glucose Monitoring Shift: Why CDC’s 2026 Metabolic Screening Overhaul Signals a Structural Break From Reactive Medicine


© 2026 Blue Skies Journal. All rights reserved. Peer-reviewed academic insights and premium journalism for institutional and individual analysts.